Progress in antisenescence biomaterials for improved osteoarthritis therapy
Source abstract
Abstract
Osteoarthritis (OA) is a degenerative joint disease closely associated with aging for which current treatments are limited primarily to symptomatic relief and fail to reverse pathological progression. A growing body of evidence indicates that the accumulation of senescent cells is a central driver of OA pathogenesis. This review systematically summarizes the latest advancements in antisenescence biomaterials for OA therapy, emphasizing their potential to overcome the limitations of conventional approaches by improving drug targeting, prolonging drug release kinetics, and increasing bioavailability. We categorize these biomaterials on the basis of their antisenescence mechanism and delivery platform, including polymeric nanoparticles (NPs), nanozymes, lipid nanoparticles (LNPs), extracellular vesicles (EVs), hydrogels, and composite hydrogels. These systems have demonstrated efficacy in selectively eliminating senescent cells through various molecular mechanisms such as modulating mitochondrial dysfunction, inflammatory signaling, DNA damage, mechanical overload and autophagy. Furthermore, this review proposes innovative strategies that integrate cellular reprogramming, organelle-targeted therapy, the artificial intelligence (AI)-guided design of antisenescence materials, and stem cell/organoid technologies to address challenges such as barriers to drug delivery and the heterogeneity of the aging microenvironment. Although these biomaterials still require further validation regarding safety, scalability, and regulatory approval for their clinical translation, antisenescence biomaterials represent multidimensional and sustainable therapeutic options for OA and hold promise for reshaping the therapeutic landscape of degenerative joint diseases by targeting the root causes of tissue degeneration. STATEMENT OF SIGNIFICANCE: Osteoarthritis (OA) is an age-related joint disease for which current therapies provide only symptom relief without halting progression. Increasing evidence shows that senescent cells drive OA development. This review summarizes recent advances in antisenescence biomaterials, including nanoparticles, nanozymes, lipid carriers, extracellular vesicles, and hydrogels. These systems improve drug targeting, prolong release, and enhance bioavailability while selectively eliminating senescent cells through mechanisms such as regulating mitochondrial dysfunction, inflammation, and DNA damage. We also highlight innovative approaches integrating cellular reprogramming, organelle-targeted therapy, AI-guided design, and stem cell technologies. Although further validation is required, antisenescence biomaterials offer sustainable strategies that target OA at its root, reshaping future treatment of degenerative joint diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Extracellular vesicles in disease · Osteoarthritis Treatment and Mechanisms · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Epidemiology and burden of osteoarthritis10.1093/bmb/lds038 ↗
2. Fabellar prevalence, degeneration and association with knee osteoarthritis in the Chinese population10.1038/s41598-019-49174-1 ↗
3. Clinical efficacy and safety of the combination of mesenchymal stem cells and scaffolds in the treatment of knee osteoarthritis: protocol for systematic review and meta-analysis
4. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 202110.1016/S2665-9913(23)00163-7 ↗
5. Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States10.1016/j.joca.2019.07.002 ↗
6. Osteoarthritis: a disease of the joint as an organ10.1002/art.34453 ↗
7. Senescent cells and osteoarthritis: a painful connection10.1172/JCI95147 ↗
8. Aging, cell senescence, the pathogenesis and targeted therapies of osteoarthritis
9. Senescence in osteoarthritis: from mechanism to potential treatment10.1186/s13075-022-02859-x ↗
10. METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression10.1136/annrheumdis-2021-221091 ↗
11. Senescent tissue-resident mesenchymal stromal cells are an internal source of inflammation in Human osteoarthritic cartilage
12. MFG-E8 regulated by miR-99b-5p protects against osteoarthritis by targeting chondrocyte senescence and macrophage reprogramming via the NF-κb pathway10.1038/s41419-021-03800-x ↗
13. Extracellular vesicles from mesenchymal stromal cells: therapeutic perspectives for targeting senescence in osteoarthritis10.1016/j.addr.2021.113836 ↗
14. Targeting cellular senescence in aging and age-related diseases: challenges, considerations, and the emerging role of senolytic and senomorphic therapies
15. Senolytic drugs: reducing senescent cell viability to extend health span10.1146/annurev-pharmtox-050120-105018 ↗
16. Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance10.1038/s41467-022-33226-8 ↗
17. Age-associated downregulation of vasohibin-1 in vascular endothelial cells10.1111/acel.12497 ↗
18. Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes10.1016/j.joca.2015.03.024 ↗
19. In vitro characterization of doxorubicin-mediated stress-induced premature senescence in Human chondrocytes10.3390/cells11071106 ↗
20. Mechanical overloading causes mitochondrial superoxide and SOD2 imbalance in chondrocytes resulting in cartilage degeneration10.1038/srep11722 ↗
21. Immunology of aging: the birth of inflammaging10.1007/s12016-021-08899-6 ↗
22. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases10.1093/gerona/glu057 ↗
23. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis10.1093/eurheartj/ehz919 ↗
24. Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis10.1038/s41413-024-00375-z ↗
25. IKKβ-NF-κb signaling in adult chondrocytes promotes the onset of age-related osteoarthritis in mice10.1126/scisignal.abf3535 ↗
26. STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κb signaling pathway10.1038/s41419-020-03341-9 ↗
27. IκB-ζ signaling promotes chondrocyte inflammatory phenotype, senescence, and erosive joint pathology10.1038/s41413-021-00183-9 ↗
28. Kat7 accelerates osteoarthritis disease progression through the TLR4/NF-κb signaling pathway10.1007/s00109-025-02519-y ↗
29. MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis10.1016/j.joca.2019.11.011 ↗
30. Is osteoarthritis a mitochondrial disease? What is the evidence10.1097/BOR.0000000000000855 ↗
31. Oxidative stress induces persistent telomeric DNA damage responsible for nuclear morphology change in mammalian cells10.1371/journal.pone.0110963 ↗
32. Mitochondrial quality control in cartilage damage and osteoarthritis: new insights and potential therapeutic targets10.1016/j.joca.2021.10.009 ↗
33. Chondrocyte ferroptosis contribute to the progression of osteoarthritis10.1016/j.jot.2020.09.006 ↗
34. Lectin-induced oxidative stress in human platelets10.1016/j.redox.2020.101456 ↗
35. Telomeres and mitochondrial metabolism: implications for cellular senescence and age-related diseases10.1007/s12015-022-10370-8 ↗
36. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
37. Phenothiazine normalizes the NADH/NAD(+) ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease10.1016/j.redox.2019.101164 ↗
38. The coordinated regulation of mitochondrial structure and function by Drp1 for mitochondrial quality surveillance10.5483/BMBRep.2019.52.2.032 ↗
39. Dipeptidyl peptidase 4 (DPP4) exacerbates osteoarthritis progression in an enzyme-independent manner
40. Inhibition of Klf10 attenuates oxidative stress-induced senescence of chondrocytes via modulating mitophagy10.3390/molecules28030924 ↗
41. Inhibition of Cpt1a alleviates oxidative stress-induced chondrocyte senescence via regulating mitochondrial dysfunction and activating mitophagy10.1016/j.mad.2022.111688 ↗
42. The role of mitochondrial quality control mechanisms in chondrocyte senescence10.1016/j.exger.2024.112379 ↗
43. A plant-derived natural photosynthetic system for improving cell anabolism10.1038/s41586-022-05499-y ↗
44. LONP1 downregulation with ageing contributes to osteoarthritis via mitochondrial dysfunction10.1016/j.freeradbiomed.2022.08.038 ↗
45. Sirtuin 4 (Sirt4) downregulation contributes to chondrocyte senescence and osteoarthritis via mediating mitochondrial dysfunction10.7150/ijbs.85585 ↗
46. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus10.1038/nrm2594 ↗
47. TRPV4 and PIEZO channels mediate the mechanosensing of chondrocytes to the biomechanical microenvironment
48. Therapeutic targets in aging-related osteoarthritis: a focus on the extracellular matrix homeostasis10.1016/j.lfs.2025.123487 ↗
49. G protein coupled estrogen receptor attenuates mechanical stress-mediated apoptosis of chondrocyte in osteoarthritis via suppression of Piezo110.1186/s10020-021-00360-w ↗
50. Mechanical overloading induces GPX4-regulated chondrocyte ferroptosis in osteoarthritis via Piezo1 channel facilitated calcium influx10.1016/j.jare.2022.01.004 ↗
51. Mechanical stress abnormalities promote chondrocyte senescence - the pathogenesis of knee osteoarthritis10.1016/j.biopha.2023.115552 ↗
52. Piezo1 transforms mechanical stress into pro senescence signals and promotes osteoarthritis severity10.1016/j.mad.2023.111880 ↗
53. The PIEZO1/miR-155-5p/GDF6/SMAD2/3 signaling axis is involved in inducing the occurrence and progression of osteoarthritis under excessive mechanical stress10.1016/j.cellsig.2024.111142 ↗
54. The effect of aging and mechanical loading on the metabolism of articular cartilage10.3899/jrheum.160226 ↗
55. RPL35 downregulated by mechanical overloading promotes chondrocyte senescence and osteoarthritis development via Hedgehog-Gli1 signaling10.1016/j.jot.2024.01.003 ↗
56. Predisposal of interferon regulatory factor 1 deficiency to accumulate DNA damage and promote osteoarthritis development in cartilage10.1002/art.42815 ↗
57. Barasertib impedes chondrocyte senescence and alleviates osteoarthritis by mitigating the destabilization of heterochromatin induced by AURKB10.1016/j.biopha.2023.115343 ↗
58. Maintenance of nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis10.1016/j.celrep.2019.02.088 ↗
59. Stabilizing heterochromatin by DGCR8 alleviates senescence and osteoarthritis10.1038/s41467-019-10831-8 ↗
60. In vitro study to identify ligand-independent function of estrogen receptor-α in suppressing DNA damage-induced chondrocyte senescence
61. Hallmarks of aging: an expanding universe10.1016/j.cell.2022.11.001 ↗
62. Autophagy in healthy aging and disease10.1038/s43587-021-00098-4 ↗
63. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence10.1080/15548627.2019.1659612 ↗
64. Caffeine protects skin from oxidative stress-induced senescence through the activation of autophagy10.7150/thno.28778 ↗
65. Activation of the leptin pathway by high expression of the long form of the leptin receptor (Ob-Rb) accelerates chondrocyte senescence in osteoarthritis10.1302/2046-3758.89.BJR-2018-0325.R2 ↗
66. Protocatechuic aldehyde attenuates chondrocyte senescence via the regulation of PTEN-induced kinase 1/Parkin-mediated mitochondrial autophagy10.1177/03946320241271724 ↗
67. Inflammaging and oxidative stress in Human diseases: from molecular mechanisms to novel treatments10.3390/ijms20184472 ↗
68. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?10.1155/2016/5698931 ↗
69. The multifaceted protective role of nuclear factor erythroid 2-related factor 2 in osteoarthritis: regulation of oxidative stress and inflammation10.2147/JIR.S479186 ↗
70. Arbutin-modified microspheres prevent osteoarthritis progression by mobilizing local anti-inflammatory and antioxidant responses
71. Saikosaponin D alleviates inflammatory response of osteoarthritis and mediates autophagy via elevating microRNA-199-3p to target transcription Factor-410.1186/s13018-024-04607-0 ↗
72. Daurisoline attenuates H(2)O(2)-induced chondrocyte autophagy by activating the PI3K/akt/mTOR signaling pathway10.1186/s13018-023-03717-5 ↗
73. MMP13 is a critical target gene during the progression of osteoarthritis10.1186/ar4133 ↗
74. NF-κb signaling pathways in osteoarthritic cartilage destruction10.3390/cells8070734 ↗
75. The role of senescent cells in ageing10.1038/nature13193 ↗
76. Cellular senescence in aging primates10.1126/science.1122446 ↗
77. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders10.1038/nature10600 ↗
78. Cellular senescence in osteoarthritis pathology10.1111/acel.12562 ↗
79. The role of chondrocyte hypertrophy and senescence in osteoarthritis initiation and progression10.3390/ijms21072358 ↗
80. PDZK1 protects against mechanical overload-induced chondrocyte senescence and osteoarthritis by targeting mitochondrial function10.1038/s41413-024-00344-6 ↗
81. Piezo1 exacerbates inflammation-induced cartilaginous endplate degeneration by activating mitochondrial fission via the Ca(2+)/CaMKII/Drp1 axis
82. Transplanted senescent cells induce an osteoarthritis-like condition in mice
83. Targeting the senescence-related genes MAPK12 and FOS to alleviate osteoarthritis10.1016/j.jot.2024.06.008 ↗
84. Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation10.1038/s41419-023-05856-3 ↗
85. Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype10.1186/s12979-019-0169-4 ↗
86. Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis10.1186/s13075-022-02747-4 ↗
87. Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis10.18632/aging.103177 ↗
88. Senolytic drugs relieve pain by reducing peripheral nociceptive signaling without modifying joint tissue damage in spontaneous osteoarthritis10.18632/aging.204204 ↗
89. ROS/TGF-β signal mediated accumulation of SOX4 in OA-FLS promotes cell senescence10.1016/j.exger.2021.111616 ↗
90. GATD3A-deficiency-induced mitochondrial dysfunction facilitates senescence of fibroblast-like synoviocytes and osteoarthritis progression10.1038/s41467-024-55335-2 ↗
91. Lactate-upregulated ARG2 expression induces cellular senescence in fibroblast-like synoviocytes of osteoarthritis via activating the mTOR/S6K1 signaling pathway10.1016/j.intimp.2024.113071 ↗
92. Strontium ion attenuates osteoarthritis through inhibiting senescence and enhancing autophagy in fibroblast-like synoviocytes10.1007/s11033-022-08112-7 ↗
93. JAK-STAT signaling mediates the senescence of cartilage-derived stem/progenitor cells10.1007/s10735-022-10086-6 ↗
94. TGF-β/Alk5 signaling prevents osteoarthritis initiation via regulating the senescence of articular cartilage stem cells10.1002/jcp.30231 ↗
95. Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA10.1186/s13287-020-01708-5 ↗
96. Intraarticular senescent chondrocytes impair the cartilage regeneration capacity of mesenchymal stem cells10.1186/s13287-019-1193-1 ↗
97. Senescence-driven inflammatory and trophic microenvironment imprints mesenchymal stromal/stem cells in osteoarthritic patients10.3390/biomedicines11071994 ↗
98. WNT10A induces apoptosis of senescent synovial resident stem cells through wnt/calcium pathway-mediated HDAC5 phosphorylation in OA joints10.1016/j.bone.2021.116006 ↗
99. Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients10.1186/s13287-022-02901-4 ↗
100. ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression10.1038/s12276-023-01059-0 ↗